Collegium Pharmaceutical, Inc. (COLL)

NASDAQ: COLL · Real-Time Price · USD

33.54

-0.14 (-0.42%)

At close: Jun 18, 2026, 4:00 PM EDT

33.86

+0.32 (0.95%)

After-hours: Jun 18, 2026, 6:48 PM EDT

Collegium Pharmaceutical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	796.33	780.57	631.45	566.77	463.93	276.87
Revenue Growth (YoY)	19.88%	23.61%	11.41%	22.17%	67.56%	-10.69%
Cost of Revenue	313.15	317.31	254.11	240.6	254.45	126.25
Gross Profit	483.18	463.26	377.34	326.17	209.49	150.62
Selling, General & Admin	294.73	284.8	210.36	159.21	172.19	118.96
Research & Development	-	-	-	-	3.98	9.45
Other Operating Expenses	-0.4	-1.18	-2.91	-	-	4.58
Total Operating Expenses	294.33	283.62	207.45	159.21	176.17	132.99
Operating Income	188.85	179.64	169.9	166.96	33.32	17.63
Interest Income	12.77	11.29	13.98	15.62	1.05	0.01
Interest Expense	-77.38	-82.31	-73.97	-83.34	-63.21	-21.01
Other Non-Operating Income (Expense)	-15.99	-15.99	-11.33	-23.5	-	-
Total Non-Operating Income (Expense)	-80.61	-87.02	-71.33	-91.23	-62.17	-21
Pretax Income	108.24	92.62	98.57	75.73	-28.85	-3.37
Provision for Income Taxes	33.29	29.75	29.38	27.58	-3.85	-74.89
Net Income	74.95	62.87	69.19	48.16	-25	71.52
Net Income to Common	74.95	62.87	69.19	48.16	-25	71.52
Net Income Growth	70.75%	-9.13%	43.68%	-	-	167.33%
Shares Outstanding (Basic)	32	32	32	34	34	35
Shares Outstanding (Diluted)	40	40	40	42	34	41
Shares Change (YoY)	3.36%	-1.79%	-3.26%	23.53%	-17.58%	16.77%
EPS (Basic)	2.37	1.98	2.14	1.43	-0.74	2.05
EPS (Diluted)	2.04	1.73	1.86	1.29	-0.74	1.86
EPS Growth	67.21%	-6.99%	44.19%	-	-	144.74%
Free Cash Flow	329.83	327.58	203.33	274.29	122.61	101.61
Free Cash Flow Growth	0.69%	61.11%	-25.87%	123.71%	20.66%	14.95%
Free Cash Flow Per Share	8.32	8.25	5.03	6.56	3.62	2.48
Gross Margin	60.68%	59.35%	59.76%	57.55%	45.15%	54.40%
Operating Margin	23.71%	23.01%	26.91%	29.46%	7.18%	6.37%
Profit Margin	9.41%	8.05%	10.96%	8.50%	-5.39%	25.83%
FCF Margin	41.42%	41.97%	32.20%	48.40%	26.43%	36.70%
EBITDA	358.82	405.71	339.06	316.22	172.26	86.55
EBITDA Margin	45.06%	51.98%	53.69%	55.79%	37.13%	31.26%
EBIT	188.85	179.64	169.9	166.96	33.32	17.63
EBIT Margin	23.71%	23.01%	26.91%	29.46%	7.18%	6.37%
Effective Tax Rate	30.75%	32.12%	29.80%	36.41%	13.33%	2219.65%

SEC Filings: 10-K · 10-Q